• Pharming’s APDS drug scores EU orphan status pharmatimes
    October 22, 2020
    Pharming’s investigational treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) has been granted orphan drug designation from the European Commission.
PharmaSources Customer Service